Acelity to Sell LifeCell Business Unit to Allergan
SAN ANTONIO Acelity L.P. today announced a definitive agreement with Allergan for the acquisition of Acelity’s LifeCell business unit for $2.9 billion in cash. Upon completion of the transaction,...
View Articleノボキュア・オプチューン(NovoTTF-100A)が 神経膠芽腫の治療用機器として厚生労働省より初発患者への適用拡大を承認
ジャージー州セント・ヘリア発 (ビジネスワイヤ) — ノボキュア社(NASDAQ:...
View ArticleExelixis and Ipsen amend exclusive licensing agreement for the...
PARIS & SOUTH SAN FRANCISCO, Calif. Regulatory News: Exelixis, Inc. (NASDAQ: EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) today jointly announced an amendment to the exclusive collaboration and...
View Articleサルタリス・メディカル・デバイシズが米国FDAからSMD-Sr90-DA小線源で510(k)認証を取得
米アリゾナ州ツーソン (ビジネスワイヤ) — サルタリス・メディカル・デバイシズ(SalutarisMD®)は、米国食品医薬品局(FDA)から当社のSMD-Sr90-DA™小線源で510(k)認証を取得しました。SMD-Sr90-DA™デバイスは上強膜小線源療法が適応となります。本デバイスはマニュアルの小線源アプリケーターシステムでの使用を意図しています。 このSmart News...
View ArticleZipLine® Medical的无创Zip®皮肤闭合系统获得中国国家食品药品监督管理局(CFDA)核准
加州坎贝尔 (美国商业资讯) — 皮肤闭合领域的创新者ZipLine® Medical, Inc.今天宣布,中国国家食品药品监督管理总局(CFDA)已核准其Zip®外科皮肤闭合器械在中国上市。凭借该核准,公司将进军价值5.43亿美元的中国伤口闭合器械市场,为4000多万台手术提供服务,包括已显示出Zip显著收益的不断增加的专科,例如骨科的全关节置换术和产科的剖腹产及子宫切除术。ZipLine...
View ArticleProvectus Biopharmaceuticals Announces Two Poster Presentations on PV-10 for...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or “The Company”), today...
View ArticleCORRECTING and REPLACING Provectus Biopharmaceuticals Announces Two Poster...
KNOXVILLE, Tenn. In the subhead and third paragraph of the release, the dates for the Asian Pacific Association for the Study of the Liver (APASL) Conference should read February 15-19, 2017. The...
View Articleオクタファルマ、発展途上国の血友病A患者が利用できるようNuwiq®をWFH人道支援プログラムに寄付
スイス・ラッヘン (ビジネスワイヤ) — オクタファルマは、当社の第4世代ヒト細胞株由来組み換え型第VIII因子製剤(Nuwiq®)450万ユニットを世界血友病連盟(WFH)の人道支援プログラムに慈善活動として寄付したとことを発表します。...
View ArticleOctapharma向WFH人道主义援助项目捐赠Nuwiq®,使发展中国家的血友病A患者能够得到治疗
瑞士拉亨 (美国商业资讯) — Octapharma自豪地宣布,该公司已向世界血液科联盟(WFH)人道主义援助项目捐赠了450万份Nuwiq®,Nuwiq®是该公司的第四代人类细胞系衍生重组第VIII因子产品。...
View ArticleMasimo Reaffirms Commitment to India with Launch of Advanced Monitoring...
BANGALORE, India Masimo (NASDAQ: MASI) announced today the launch and availability of the Rad-97™ Pulse-CO Oximeter®* and Next Generation SedLine®* Brain Function Monitoring in India. The...
View ArticleCellMax Life Takes Liquid Biopsy to Next Level with 73 Gene Profile ctDNA...
SUNNYVALE, Calif. CellMax Life, the precision cancer testing company, announced today the commercial availability of CellMax-LBx Liquid Biopsy in India. CellMax-LBx is a cancer blood test which...
View ArticleBridgeBio Pharma成立,专注于治疗基因疾病的精准药物
加州帕罗奥图 (美国商业资讯) — 总部位于加州的BridgeBio Pharma已走出隐身模式,以披露有关其开发治疗基因疾病新药创新之道的更多细节。这些疾病通常具有遗传性和个体罕见性,整体而言,单在美国就有数千万名病患受到此类疾病的摧残,其中许多是儿童。公司成立于2015年,主要重点是上市前产品,运用其采购和运营优势,在开发的各个阶段寻找和构建价值。 BridgeBio...
View ArticleiCarbonX Expands Digital Life Alliance to Accelerate Development of Global...
SHENZHEN, China At the first Digital Life Summit, iCarbonX founder Jun Wang announced that seven companies have joined iCarbonX’s Digital Life Alliance and will collaborate to give people a deeper...
View ArticleLombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP...
OXFORDSHIRE, England Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced approval from...
View ArticleMasimo重申对印度市场的承诺,推出专为印度打造的先进监护技术
印度班加罗尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布在印度推出并发售Rad-97™脉搏碳氧氧饱和度仪®*和下一代SedLine®*脑功能监护仪。该消息是Masimo创始人、首席执行官Joe Kiani在班加罗尔召开的班加罗尔顶级医院院长圆桌会议上宣布的。 Masimo创始人、首席执行官Joe...
View ArticleTribogenics Signs HORIBA Scientific as Distribution Partner for Southeast Asia
LOS ANGELES & SINGAPORE Tribogenics, a leader in triboluminescence based spectroscopy, announced today that it has signed HORIBA Scientific to distribute the company’s new line of Watson™...
View Articleマシモがインド向けの高度なモニタリング技術の市場投入により同国へのコミットメントを再確認
印バンガロール (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、Rad-97™ Pulse-CO...
View ArticleMinomic Announces Clinical Study Update for MILGa in Prostate, Bladder and...
SYDNEY Minomic International Ltd (Minomic) is an immuno-oncology company specializing in therapeutics and diagnostics for solid tumors, including prostate, bladder and pancreas. The Company today...
View ArticleLFB S.A.今天宣布,美国食品药品管理局已受理该公司递交的重组凝血VIIa因子(活化β eptacog)生物制剂许可证申请
法国于利斯 (美国商业资讯) — LFB S.A.宣布,美国食品药品管理局(FDA)已受理该公司的生物制剂许可证申请(BLA),该BLA申报(重组)凝血VIIa因子的上市核准,该因子用于治疗先天性血友病A或B青少年及伴有抑制因子的成人先天性血友病A或B患者。该BLA包含全球性PERSEPT(Program for the Evaluation of Recombinant Factor...
View Article